Endo Says Drop Direct Buyers' Cert. Bid In Pay For Delay Row
Endo Pharmaceuticals has urged an Illinois federal judge to toss a class certification bid by direct buyers of medication in multidistrict litigation who claim they overpaid for the painkiller Opana ER,...To view the full article, register now.
Already a subscriber? Click here to view full article